The discovery of GLP-1 by Joel Habener and Svetlana Mojsov in the 1980s, and Lotte Knudsen’s development sustained-acting versions of this hormone for obesity in 2000, has been summarized by Friedman [21]. Here, GLP1R is linked to obesity disorder.